Abstract

Emerging studies indicate that extracellular vesicles (EVs) and their inner circular RNAs (circRNAs), play key roles in the gene regulatory network and cardiovascular repair. However, our understanding of EV-derived circRNAs in cardiac remodeling after myocardial infarction (MI) remains limited. Here we show that the level of circCEBPZOS is downregulated in serum EVs of patients with the adverse cardiac remodeling compared with those without post-MI remodeling or normal subjects. Loss-of-function approaches in vitro establish that circCEBPZOS robustly promote angiogenesis. Overexpression of circCEBPZOS in mice attenuates MI-induced left ventricular dysfunction, accompanied by a larger functional capillary network at the border zone. Further exploration of the downstream target gene indicates that circCEBPZOS acts as a competing endogenous RNA by directly binding to miR-1178-3p and thereby inducing transcription of its target gene phosphoinositide-dependent kinase-1 (PDPK1). Together, our results reveal that circCEBPZOS attenuates detrimental post-MI remodeling via the miR-1178-3p/PDPK1 axis, which facilitates revascularization, ultimately improving the cardiac function.

The circular RNA circCEBPZOS, present in extracellular vesicles, promotes revascularization and alleviates postinfarct cardiac remodeling.

Details

Title
Extracellular vesicle-derived circCEBPZOS attenuates postmyocardial infarction remodeling by promoting angiogenesis via the miR-1178-3p/PDPK1 axis
Author
Yu, Ling 1 ; Liang, Yubin 2 ; Zhang, Minzhou 3   VIAFID ORCID Logo  ; Yang, Phillip C. 4 ; Hinek, Aleksander 5 ; Mao, Shuai 6   VIAFID ORCID Logo 

 Guangzhou University of Chinese Medicine, The Second Clinical College, Guangzhou, China (GRID:grid.411866.c) (ISNI:0000 0000 8848 7685); Guangdong Provincial Hospital of Chinese Medicine, Department of Critical Care Medicine, Guangzhou, China (GRID:grid.413402.0) (ISNI:0000 0004 6068 0570) 
 Guangzhou University of Chinese Medicine, The Second Clinical College, Guangzhou, China (GRID:grid.411866.c) (ISNI:0000 0000 8848 7685) 
 Guangzhou University of Chinese Medicine, The Second Clinical College, Guangzhou, China (GRID:grid.411866.c) (ISNI:0000 0000 8848 7685); Guangdong Provincial Hospital of Chinese Medicine, Department of Critical Care Medicine, Guangzhou, China (GRID:grid.413402.0) (ISNI:0000 0004 6068 0570); Guangdong Provincial Branch of National Clinical Research Centre for Chinese Medicine Cardiology, Guangzhou, China (GRID:grid.413402.0) 
 Division of Cardiovascular Medicine, Stanford University School of Medicine, Department of Medicine, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956) 
 Hospital for Sick Children, Translational Medicine, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646) 
 Guangzhou University of Chinese Medicine, The Second Clinical College, Guangzhou, China (GRID:grid.411866.c) (ISNI:0000 0000 8848 7685); Guangdong Provincial Hospital of Chinese Medicine, Department of Critical Care Medicine, Guangzhou, China (GRID:grid.413402.0) (ISNI:0000 0004 6068 0570); Guangdong Provincial Branch of National Clinical Research Centre for Chinese Medicine Cardiology, Guangzhou, China (GRID:grid.413402.0); Division of Cardiovascular Medicine, Stanford University School of Medicine, Department of Medicine, Stanford, USA (GRID:grid.168010.e) (ISNI:0000000419368956) 
Pages
133
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2771490645
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.